Neurostimulation Devices | Market Insights | Europe (Supplemental) | 2022
The European neurostimulation device market has been strongly impacted by the COVID-19 pandemic; however, following this impact, it will grow modestly, fueled by the ongoing product innovation to improve treatment efficacy and to address new indications, favorable demographic trends, new competitors entering the market, and ongoing postmarket clinical studies. However, limited reimbursement and the preference for alternative treatments in the neurostimulation device market segments will limit the growth of the overall market.
This Medtech 360 Report provides key market metrics for neurostimulation devices in Europe, including country-level data for major countries and aggregate data for the rest of Europe, across an 11-year period.
